Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

German finance minister says to receive AstraZeneca COVID vaccine

Fri, 16th Apr 2021 10:24

BERLIN, April 16 (Reuters) - German Finance Minister Olaf
Scholz said he was due to receive his first shot of
AstraZeneca's COVID-19 vaccine on Friday.

"I have always said I would get vaccinated when it is my
turn," the 62-year-old politician told journalists on Friday.
"Today is the day. Immediately afterwards, I will receive a jab
of the AstraZeneca vaccine."

According to German media reports, Chancellor Angela Merkel,
66, will also receive the AstraZeneca vaccine on Friday. The
chancellery declined to confirm the reports.

Germany's vaccine regulator has recommended limiting the use
of AstraZeneca's vaccine to those aged over 60, citing risks of
a rare clotting condition.

Questions over the safety of the AstraZeneca vaccine as well
as a similar one made by Johnson & Johnson threaten to
undermine public confidence in the low-cost shots, which
authorities had been counting on in the fight against a pandemic
that has claimed more than 3 million lives worldwide.

European Commission President Ursula von der Leyen, a former
minister in Merkel's government, received a shot of the vaccine
made by BioNTech and Pfizer on Thursday.
(Reporting by Sabine Siebold; Writing by Maria Sheahan
Editing by Gareth Jones)

Related Shares

More News
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.